Lidocaine/phenylephrine/tropicamide

Drug Profile

Lidocaine/phenylephrine/tropicamide

Alternative Names: Fydrane; Mydane; Mydrane; Mydricaine; T2380

Latest Information Update: 15 Dec 2015

Price : $50

At a glance

  • Originator Laboratoires Thea
  • Class Acetanilides; Antihypotensives; Ethanolamines; Eye disorder therapies; Local anaesthetics; Mydriatics; Pyridines; Small molecules
  • Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Anaesthesia; Miosis

Most Recent Events

  • 01 Jul 2015 Registered for Anaesthesia in Czech Republic (Intraocular)
  • 01 Jul 2015 Registered for Anaesthesia in France, Spain, Belgium, Portugal, Germany, Austria, Italy, Bulgaria, Italy, Sweden, Cyprus, Denmark, Greece, Finland, Croatia, Iceland, Luxembourg, Netherlands, Poland, Romania, Slovenia, Slovakia, United Kingdom, Ireland, Norway (Intraocular)
  • 01 Jul 2015 Registered for Miosis (Prevention) in Czech Republic (Intraocular)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top